Showing results (41-50 of 101) with videos related to
Sort By:
Pageof 11
Urology|August 8, 2001
Addition of radiation therapy to androgen ablation improves outcome for subclinically node-positive prostate cancerG K Zagars, A Pollack, A C von EschenbachInternational Journal of Radiation Oncology, Biology, Physics|August 30, 1995
Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigenG K Zagars, A Pollack, A C von EschenbachCancer|June 1, 1993
Dedifferentiation of locally recurrent prostate cancer after radiation therapy. Evidence for tumor progressionJ A Wheeler, G K Zagars, A G AyalaCancer|August 15, 1997
Management of unfavorable locoregional prostate carcinoma with radiation and androgen ablationG K Zagars, A Pollack, A C von EschenbachRadiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 1, 1987
An explanatory hypothesis for early- and late-effect parameter values in the LQ modelT E Schultheiss, G K Zagars, L J PetersInternational Journal of Radiation Oncology, Biology, Physics|December 1, 1990
The role of serum prostatic acid phosphatase in the management of adenocarcinoma of the prostate with radiotherapyJ C Carlton, G K Zagars, M J OswaldCancer|April 1, 1997
Prognostic factors for clinically localized prostate carcinoma: analysis of 938 patients irradiated in the prostate specific antigen eraG K Zagars, A Pollack, A C von EschenbachCancer|January 15, 1991
Prostate-specific antigen and external beam radiation therapy in prostate cancerG K Zagars, N E Sherman, R J BabaianRadiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 1, 1987
Inter-tumor heterogeneity and radiation dose-control curvesG K Zagars, T E Schultheiss, L J PetersCancer|September 1, 1993
Prognostic factors in prostate cancer. Analysis of 874 patients treated with radiation therapyG K Zagars, A C von Eschenbach, A G AyalaPageof 11